Boston-based investment firm Allied Minds has founded a new medical device company, Precision Biopsy, in cooperation with the University of Colorado. The new firm is developing an “optical” biopsy needle for diagnosing prostate cancer; the device uses spectroscopy to differentiate between normal and malignant tissue in real-time. Allied Minds specializes in very early-stage investments in projects spun out of academia.
